Vectorpharma SpA - Bic Friuli Venezia Giulia S.p.A. -

An associated companies presently operating at BIC Trieste, BIC Friuli-Venezia Giulia S.p.A.established in Trieste in 1989 by SPI - Promozione e Sviluppo Imprenditoriale SpA (IRI Group).
VECTORPHARMA operates in the field of research, development and manufacturing of new drug delivery systems. VECTORPHARMA technology optimises drug absorption through a better control of the release. The company has registered over 15 patents in all major countries.
VECTORPHARMA in Italy: This is our primary site with our Research, Development and Production for Europe. The company was founded in 1988 to exploit the potential for applying advanced physical chemical concepts to drug delivery. Patents are pending in Europe and USA.
VECTORPHARMA in U.S.A.: In the United States we have our business headquarters. We also have production in FDA approved facilities through our Joint Venture with Eon Labs in New York. VECTORPHARMA is focusing its efforts on oral, dermal and transdermal applications of its Physical Chemistry inventions. As a consequence, it has decided to sell or license its injectable biodegradable micro-sphere technology.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Drug delivery
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe , North America

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: